$BSTCE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOSPECIFICS TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOSPECIFICS TECHNOLOGIES CORP. Get notifications about new insider transactions in BIOSPECIFICS TECHNOLOGIES CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 04 2013 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Sell | S | 18.30 | 946 | 17,312 | 36,247 | 37.2 K to 36.2 K (-2.54 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Sell | S | 0.01 | 9,000 | 90 | 676,381 | 685.4 K to 676.4 K (-1.31 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.07 | 178,265 | 2,508,189 | 685,381 | 507.1 K to 685.4 K (+35.15 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Sell | S | 0.01 | 9,750 | 98 | 507,116 | 516.9 K to 507.1 K (-1.89 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 13.49 | 200 | 2,698 | 516,866 | 516.7 K to 516.9 K (+0.04 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.17 | 200 | 2,834 | 516,666 | 516.5 K to 516.7 K (+0.04 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.35 | 400 | 5,740 | 516,466 | 516.1 K to 516.5 K (+0.08 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 13.95 | 199 | 2,776 | 516,066 | 515.9 K to 516.1 K (+0.04 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.08 | 400 | 5,632 | 515,867 | 515.5 K to 515.9 K (+0.08 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.28 | 400 | 5,712 | 515,467 | 515.1 K to 515.5 K (+0.08 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.83 | 200 | 2,966 | 515,067 | 514.9 K to 515.1 K (+0.04 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.69 | 800 | 11,752 | 514,867 | 514.1 K to 514.9 K (+0.16 %) |
Mar 18 2013 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | 10% Owner | Buy | P | 14.89 | 594 | 8,845 | 514,067 | 513.5 K to 514.1 K (+0.12 %) |
Feb 28 2013 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | A | 21.00 | 50,000 | 1,050,000 | 275,000 | |
Sep 21 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 1.00 | 45,000 | 45,000 | 0 | |
Sep 21 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 1.00 | 45,000 | 45,000 | 208,644 | 163.6 K to 208.6 K (+27.50 %) |
Sep 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Option Exercise | M | 1.00 | 5,425 | 5,425 | 0 | |
Sep 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Buy | M | 1.00 | 5,425 | 5,425 | 37,193 | 31.8 K to 37.2 K (+17.08 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.06 | 963 | 17,392 | 1,714 | 2.7 K to 1.7 K (-35.97 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.15 | 858 | 15,573 | 2,677 | 3.5 K to 2.7 K (-24.27 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.16 | 142 | 2,579 | 3,535 | 3.7 K to 3.5 K (-3.86 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.62 | 1,076 | 20,035 | 3,677 | 4.8 K to 3.7 K (-22.64 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.62 | 500 | 9,310 | 4,753 | 5.3 K to 4.8 K (-9.52 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.68 | 100 | 1,868 | 5,253 | 5.4 K to 5.3 K (-1.87 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.63 | 200 | 3,726 | 5,353 | 5.6 K to 5.4 K (-3.60 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.39 | 1,000 | 18,390 | 5,553 | 6.6 K to 5.6 K (-15.26 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.26 | 1,500 | 27,390 | 6,553 | 8.1 K to 6.6 K (-18.63 %) |
Jun 13 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.21 | 1,500 | 27,315 | 8,053 | 9.6 K to 8.1 K (-15.70 %) |
Jun 08 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.74 | 101 | 1,792 | 9,553 | 9.7 K to 9.6 K (-1.05 %) |
May 31 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 21.10 | 21 | 443 | 12,154 | 12.2 K to 12.2 K (-0.17 %) |
May 31 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.00 | 100 | 1,700 | 12,175 | 12.3 K to 12.2 K (-0.81 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.35 | 1,395 | 24,203 | 9,654 | 11 K to 9.7 K (-12.63 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.40 | 100 | 1,740 | 11,049 | 11.1 K to 11 K (-0.90 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.47 | 5 | 87 | 11,149 | 11.2 K to 11.1 K (-0.04 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 16.75 | 1,000 | 16,750 | 11,154 | 12.2 K to 11.2 K (-8.23 %) |
May 24 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 16.25 | 1,000 | 16,250 | 12,275 | 13.3 K to 12.3 K (-7.53 %) |
May 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 15.63 | 1,025 | 16,020 | 13,275 | 14.3 K to 13.3 K (-7.17 %) |
May 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 16.53 | 700 | 11,571 | 14,300 | 15 K to 14.3 K (-4.67 %) |
Mar 30 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | M | 4.60 | 15,000 | 69,000 | 15,000 | |
Mar 30 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Buy | M | 4.60 | 15,000 | 69,000 | 15,000 | 0 to 15 K |
Aug 24 2011 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 1.00 | 10,000 | 10,000 | 50,000 | |
Aug 24 2011 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 1.00 | 10,000 | 10,000 | 66,425 | 56.4 K to 66.4 K (+17.72 %) |
Jun 09 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.57 | 5,000 | 122,871 | 0 | 5 K to 0 (-100.00 %) |
Jun 09 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.23 | 5,000 | 121,135 | 5,000 | 10 K to 5 K (-50.00 %) |
May 26 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.08 | 7,700 | 185,440 | 10,000 | 17.7 K to 10 K (-43.50 %) |
Jun 09 2011 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 22.25 | 20,000 | 445,000 | 163,644 | 183.6 K to 163.6 K (-10.89 %) |
May 11 2011 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 0.83 | 15,000 | 12,450 | 0 | |
May 11 2011 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 0.83 | 15,000 | 12,450 | 56,425 | 41.4 K to 56.4 K (+36.21 %) |
May 23 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.00 | 1,900 | 45,600 | 17,700 | 19.6 K to 17.7 K (-9.69 %) |
May 23 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.01 | 10,000 | 240,054 | 19,600 | 29.6 K to 19.6 K (-33.78 %) |
May 23 2011 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Sell | S | 24.18 | 400 | 9,671 | 29,600 | 30 K to 29.6 K (-1.33 %) |
Apr 06 2011 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 1.00 | 50,000 | 50,000 | 0 | |
Apr 06 2011 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 1.00 | 50,000 | 50,000 | 192,422 | 142.4 K to 192.4 K (+35.11 %) |
Dec 09 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 1.00 | 20,000 | 20,000 | 0 | |
Dec 09 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 1.00 | 20,000 | 20,000 | 133,644 | 113.6 K to 133.6 K (+17.60 %) |
Sep 15 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 23.50 | 150,000 | 3,525,000 | 1,005,179 | 1.2 M to 1 M (-12.99 %) |
Sep 15 2010 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 23.50 | 150,000 | 3,525,000 | 1,005,179 | 1.2 M to 1 M (-12.99 %) |
Sep 15 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 23.50 | 150,000 | 3,525,000 | 1,005,179 | 1.2 M to 1 M (-12.99 %) |
Apr 16 2010 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Option Exercise | M | 19.00 | 15,000 | 285,000 | 0 | |
Apr 16 2010 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Option Exercise | M | 19.00 | 15,000 | 285,000 | 15,000 | |
Apr 16 2010 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Buy | M | 19.00 | 15,000 | 285,000 | 30,000 | 15 K to 30 K (+100.00 %) |
Apr 16 2010 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Buy | M | 19.00 | 15,000 | 285,000 | 15,000 | 0 to 15 K |
Jun 10 2010 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 1.00 | 5,452 | 5,452 | 158,973 | |
Jun 10 2010 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 1.00 | 5,452 | 5,452 | 41,452 | 36 K to 41.5 K (+15.14 %) |
Apr 05 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | A | 0.83 | 50,000 | 41,500 | 100,000 | |
Feb 26 2010 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 28.83 | 10,000 | 288,300 | 626,462 | 636.5 K to 626.5 K (-1.57 %) |
Feb 24 2010 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 29.34 | 1,005 | 29,487 | 636,462 | 637.5 K to 636.5 K (-0.16 %) |
Feb 24 2010 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 29.01 | 21,303 | 618,000 | 637,467 | 658.8 K to 637.5 K (-3.23 %) |
Feb 19 2010 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 29.05 | 50,000 | 1,452,500 | 658,770 | 708.8 K to 658.8 K (-7.05 %) |
Feb 08 2010 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 28.80 | 132,833 | 3,825,590 | 708,770 | 841.6 K to 708.8 K (-15.78 %) |
Dec 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Sell | S | 30.31 | 306 | 9,275 | 31,768 | 32.1 K to 31.8 K (-0.95 %) |
Dec 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 30.00 | 100,000 | 3,000,000 | 1,155,179 | 1.3 M to 1.2 M (-7.97 %) |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Option Exercise | M | 1.00 | 10,000 | 10,000 | 164,425 | |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Option Exercise | M | 2.56 | 10,000 | 25,630 | 174,425 | |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Sell | S | 30.36 | 200 | 6,071 | 32,074 | 32.3 K to 32.1 K (-0.62 %) |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Sell | S | 30.04 | 11,254 | 338,090 | 32,274 | 43.5 K to 32.3 K (-25.85 %) |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Buy | M | 1.00 | 10,000 | 10,000 | 43,528 | 33.5 K to 43.5 K (+29.83 %) |
Dec 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Buy | M | 2.56 | 10,000 | 25,630 | 33,528 | 23.5 K to 33.5 K (+42.50 %) |
Dec 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 30.00 | 100,000 | 3,000,000 | 1,155,179 | 1.3 M to 1.2 M (-7.97 %) |
Dec 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 30.00 | 100,000 | 3,000,000 | 1,155,179 | 1.3 M to 1.2 M (-7.97 %) |
Oct 30 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 1.88 | 50,000 | 93,750 | 0 | |
Oct 30 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 1.88 | 50,000 | 93,750 | 113,644 | 63.6 K to 113.6 K (+78.56 %) |
Sep 24 2009 | BSTCE | BIOSPECIFICS TECHN ... | Geller Matthew | Director | Option Exercise | A | 30.79 | 15,000 | 461,850 | 45,000 | |
Sep 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 24.00 | 100,000 | 2,400,000 | 1,255,179 | 1.4 M to 1.3 M (-7.38 %) |
Sep 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 24.00 | 100,000 | 2,400,000 | 1,255,179 | 1.4 M to 1.3 M (-7.38 %) |
Sep 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 24.00 | 100,000 | 2,400,000 | 1,255,179 | 1.4 M to 1.3 M (-7.38 %) |
Sep 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 27.47 | 12,500 | 343,375 | 36,000 | 48.5 K to 36 K (-25.77 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 1.00 | 5,000 | 5,000 | 164,425 | |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 1.00 | 5,000 | 5,000 | 169,425 | |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 2.56 | 6,000 | 15,378 | 174,425 | |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | M | 2.56 | 4,000 | 10,252 | 180,425 | |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 26.72 | 5,480 | 146,415 | 0 | 5.5 K to 0 (-100.00 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 25.40 | 2,020 | 51,308 | 5,480 | 7.5 K to 5.5 K (-26.93 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 28.28 | 5,000 | 141,400 | 48,500 | 53.5 K to 48.5 K (-9.35 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 1.00 | 5,000 | 5,000 | 53,500 | 48.5 K to 53.5 K (+10.31 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 27.65 | 5,000 | 138,250 | 48,500 | 53.5 K to 48.5 K (-9.35 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 1.00 | 5,000 | 5,000 | 53,500 | 48.5 K to 53.5 K (+10.31 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 27.00 | 6,000 | 161,994 | 48,500 | 54.5 K to 48.5 K (-11.01 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 2.56 | 6,000 | 15,378 | 54,500 | 48.5 K to 54.5 K (+12.37 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 25.30 | 4,000 | 101,200 | 48,500 | 52.5 K to 48.5 K (-7.62 %) |
Sep 15 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Buy | M | 2.56 | 4,000 | 10,252 | 52,500 | 48.5 K to 52.5 K (+8.25 %) |
Sep 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Option Exercise | A | 26.43 | 15,000 | 396,450 | 184,425 | |
Sep 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Morgan Henry | Director | Option Exercise | A | 26.43 | 15,000 | 396,450 | 184,425 | |
Sep 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | A | 26.43 | 15,000 | 396,450 | 109,000 | |
Jul 22 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | X | 3.00 | 20,000 | 60,000 | 340,000 | |
Jul 22 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | X | 3.00 | 20,000 | 60,000 | 1,426,123 | 1.4 M to 1.4 M (+1.42 %) |
Jul 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Option Exercise | X | 4.60 | 15,000 | 69,000 | 30,000 | |
Jul 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Buy | X | 4.60 | 15,000 | 69,000 | 56,494 | 41.5 K to 56.5 K (+36.15 %) |
Jun 29 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Option Exercise | A | 20.95 | 15,000 | 314,250 | 45,000 | |
May 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.47 | 15,058 | 293,179 | 841,603 | 826.5 K to 841.6 K (+1.82 %) |
May 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.40 | 100 | 1,940 | 826,545 | 826.4 K to 826.5 K (+0.01 %) |
May 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.00 | 601 | 11,419 | 826,445 | 825.8 K to 826.4 K (+0.07 %) |
Apr 24 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.50 | 900 | 16,650 | 825,844 | 824.9 K to 825.8 K (+0.11 %) |
Apr 24 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.05 | 284 | 5,126 | 824,944 | 824.7 K to 824.9 K (+0.03 %) |
Apr 24 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | D | 4.00 | 2,500 | 10,000 | 360,000 | |
Apr 24 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | D | 4.25 | 1,800 | 7,650 | 362,500 | |
Apr 14 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.00 | 6,419 | 121,961 | 824,660 | 818.2 K to 824.7 K (+0.78 %) |
Apr 14 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.00 | 3,301 | 59,418 | 818,241 | 814.9 K to 818.2 K (+0.41 %) |
Apr 07 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.00 | 2,432 | 46,208 | 814,940 | 812.5 K to 814.9 K (+0.30 %) |
Apr 07 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.50 | 1,577 | 29,175 | 812,508 | 810.9 K to 812.5 K (+0.19 %) |
Mar 19 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.94 | 5,345 | 106,579 | 810,931 | 805.6 K to 810.9 K (+0.66 %) |
Mar 19 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.25 | 5,500 | 100,375 | 805,586 | 800.1 K to 805.6 K (+0.69 %) |
Feb 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 20.00 | 45,000 | 900,000 | 1,355,179 | 1.4 M to 1.4 M (-3.21 %) |
Mar 12 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.80 | 2,500 | 47,000 | 800,086 | 797.6 K to 800.1 K (+0.31 %) |
Mar 12 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 18.25 | 2,150 | 39,238 | 797,586 | 795.4 K to 797.6 K (+0.27 %) |
Feb 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 20.00 | 45,000 | 900,000 | 1,406,123 | 1.5 M to 1.4 M (-3.10 %) |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 16.75 | 500 | 8,375 | 519,159 | 518.7 K to 519.2 K (+0.10 %) | |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 17.00 | 500 | 8,500 | 518,659 | 518.2 K to 518.7 K (+0.10 %) | |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 17.00 | 100 | 1,700 | 518,159 | 518.1 K to 518.2 K (+0.02 %) | |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 17.00 | 100 | 1,700 | 518,059 | 518 K to 518.1 K (+0.02 %) | |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 1.00 | 4,264 | 4,264 | 517,959 | 513.7 K to 518 K (+0.83 %) | |
Feb 10 2009 | BSTCE | BIOSPECIFICS TECHN ... | Vogel Jeffrey Kenneth | Buy | P | 1.00 | 4,264 | 4,264 | 513,695 | 509.4 K to 513.7 K (+0.84 %) | |
Feb 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 20.00 | 45,000 | 900,000 | 1,355,179 | 1.4 M to 1.4 M (-3.21 %) |
Jan 07 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 22.00 | 1,900 | 41,800 | 795,436 | 793.5 K to 795.4 K (+0.24 %) |
Jan 07 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.50 | 1,240 | 26,660 | 793,536 | 792.3 K to 793.5 K (+0.16 %) |
Jan 07 2009 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.40 | 2,250 | 48,150 | 792,296 | 790 K to 792.3 K (+0.28 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 22.00 | 3,900 | 85,800 | 790,046 | 786.1 K to 790 K (+0.50 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.99 | 2,400 | 52,776 | 786,146 | 783.7 K to 786.1 K (+0.31 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.97 | 200 | 4,394 | 783,746 | 783.5 K to 783.7 K (+0.03 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.75 | 200 | 4,350 | 783,546 | 783.3 K to 783.5 K (+0.03 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.73 | 1,010 | 21,947 | 783,346 | 782.3 K to 783.3 K (+0.13 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.70 | 1,000 | 21,700 | 782,336 | 781.3 K to 782.3 K (+0.13 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.33 | 990 | 21,117 | 781,336 | 780.3 K to 781.3 K (+0.13 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 22.00 | 200 | 4,400 | 780,346 | 780.1 K to 780.3 K (+0.03 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 20.00 | 500 | 10,000 | 780,146 | 779.6 K to 780.1 K (+0.06 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.50 | 650 | 12,675 | 779,646 | 779 K to 779.6 K (+0.08 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.90 | 170 | 3,383 | 778,996 | 778.8 K to 779 K (+0.02 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 21.00 | 2,180 | 45,780 | 778,826 | 776.6 K to 778.8 K (+0.28 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.95 | 1,950 | 38,903 | 776,646 | 774.7 K to 776.6 K (+0.25 %) |
Dec 31 2008 | BSTCE | BIOSPECIFICS TECHN ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.93 | 200 | 3,986 | 774,696 | 774.5 K to 774.7 K (+0.03 %) |